Cite

HARVARD Citation

    Belickova, M. et al. (n.d.). 49 THE PROGNOSTIC SIGNIFICANCE OF TP53 MUTATIONS IN MDS PATIENTS WITH DEL(5Q). Leukemia research. pp. S22-S23. [Online]. 
  
Back to record